Forum Financial Management LP Makes New Investment in Tempus AI, Inc. $TEM

Key Points

• Forum Financial Management LP has acquired 8,303 shares of Tempus AI, Inc. valued at approximately $528,000 during the second quarter.
• Tempus AI's stock is currently trading at $89.23, with a 12-month high of $104.32 and a low of $31.36.
• Analysts have mixed ratings for Tempus AI, with seven having a Buy rating and a consensus price target of $79.38.

Forum Financial Management LP bought a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund bought 8,303 shares of the company's stock, valued at approximately $528,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Concord Wealth Partners increased its position in Tempus AI by 308.0% in the 2nd quarter. Concord Wealth Partners now owns 408 shares of the company's stock valued at $26,000 after buying an additional 308 shares in the last quarter. University of Texas Texas AM Investment Management Co. bought a new stake in Tempus AI during the 1st quarter worth approximately $33,000. Bartlett & CO. Wealth Management LLC grew its holdings in shares of Tempus AI by 100.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after acquiring an additional 400 shares in the last quarter. Nemes Rush Group LLC bought a new position in shares of Tempus AI in the first quarter valued at approximately $39,000. Finally, Quarry LP bought a new position in shares of Tempus AI in the first quarter valued at approximately $44,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Tempus AI Stock Up 2.5%

Shares of NASDAQ:TEM opened at $89.23 on Friday. The stock's 50-day moving average price is $84.20 and its 200-day moving average price is $67.67. Tempus AI, Inc. has a 12-month low of $31.36 and a 12-month high of $104.32. The stock has a market capitalization of $15.50 billion, a P/E ratio of -74.98 and a beta of 4.87. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.01. The company had revenue of $314.64 million for the quarter, compared to analysts' expectations of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.Tempus AI's quarterly revenue was up 89.5% on a year-over-year basis. During the same period last year, the firm earned ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. On average, equities analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Analyst Upgrades and Downgrades

TEM has been the subject of several research reports. BTIG Research increased their price objective on Tempus AI from $85.00 to $96.00 and gave the company a "buy" rating in a report on Wednesday. Piper Sandler increased their price objective on Tempus AI from $70.00 to $105.00 and gave the stock a "neutral" rating in a research report on Wednesday. Canaccord Genuity Group initiated coverage on Tempus AI in a research report on Monday. They issued a "buy" rating and a $110.00 price objective on the stock. Cowen downgraded Tempus AI from a "buy" rating to a "hold" rating in a research report on Tuesday. Finally, Weiss Ratings restated a "sell (d-)" rating on shares of Tempus AI in a research report on Wednesday, October 8th. Seven analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $79.38.

Insider Buying and Selling

In related news, COO Ryan Fukushima sold 5,000 shares of the firm's stock in a transaction dated Monday, October 6th. The stock was sold at an average price of $92.32, for a total value of $461,600.00. Following the sale, the chief operating officer directly owned 130,000 shares of the company's stock, valued at $12,001,600. This trade represents a 3.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the firm's stock in a transaction dated Thursday, September 25th. The stock was sold at an average price of $76.56, for a total value of $25,456,200.00. Following the completion of the sale, the chief executive officer directly owned 9,141,032 shares in the company, valued at $699,837,409.92. The trade was a 3.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 933,662 shares of company stock valued at $68,070,993 over the last ninety days. Corporate insiders own 26.27% of the company's stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.